Age (y) | | |
<45 | 10:47 | 1† |
45–49 | 9:31 | 1.34 (0.42–4.28) |
50–54 | 8:36 | 1.45 (0.44–4.75) |
⩾55 | 12:53 | 1.31 (0.43–3.99) |
Sex | | |
Males | 26:94 | 1† |
Females | 13:73 | 0.59 (0.24–1.44) |
Modality of infection | | |
Community acquired | 29:129 | 1† |
Parenteral | 10:38 | 1.20 (0.40–3.62) |
Duration of hepatitis (y) | | |
<10 | 18:79 | 1† |
10–19 | 7:35 | 1.00 (0.33–3.06) |
⩾20 | 14:53 | 1.22 (0.42–3.54) |
Basal value of ALT‡ | | |
<80 | 15:52 | 1† |
80–129 | 7:53 | 0.57 (0.17–1.89) |
⩾130 | 17:62 | 1.77 (0.61-5.12) |
Histology grading of baseline biopsy§ | | |
<8 | 19:84 | 1† |
8–10 | 12:51 | 1.79 (0.62–5.11) |
⩾11 | 3:18 | 0.84 (0.18–3.87) |
Missing | 5:14 | – |
Histology staging of baseline biopsy | | |
<3 | 25:75 | 1† |
3/4 | 5:32 | 0.34 (0.10–1.19) |
⩾5 | 4:46 | 0.23 (0.06–0.88) |
Missing | 5:14 | – |